RE:RE:RE:Revenue addition ...It is a 1997 old drug off patent, how long will it take for new leading edge drugs currently being developed to exitnct Exelon off the market? I can think of at least half dozen biotechs currenlty in late stage clinical trial for Alzheimer’s disease. I think GUD has blinked again as the future belongs to CRISP biotect soon to arrive for many disease. Simply look at who won the covid vaccine racee. Moderna and Bionet. Regardless good luck